<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Schaer BA</dc:creator>
  <dc:creator>Kühne MS</dc:creator>
  <dc:creator>Blatter D</dc:creator>
  <dc:creator>Osswald S</dc:creator>
  <dc:creator>Sticherling C</dc:creator>
  <dc:date>2014</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">OBJECTIVE
The implantable cardioverter defibrillator (ICD) is very effective in the prevention of sudden cardiac death, but its benefit is impaired by competing risks. A simple risk model to predict mortality was designed for patients with primary prevention and ischaemic cardiomyopathy. We aimed to apply this score to a general ICD population.


METHODS
This retrospective registry study included all patients in whom an ICD was implanted at a tertiary referral hospital. Risk factors were age &gt;70 years, QRS width &gt;120 ms, atrial fibrillation, New York Heart Association Functional Classification class &gt;2 and glomerular filtration rate &lt;60 mL/min/1.73 m(2). Kaplan-Meier curves were constructed according to the presence of 0, 1, 2 and &gt;2 risk factors.


RESULTS
The cohort consists of 1032 patients, 881 (86%) were men, mean age was 61±14 years and mean follow-up 66±46 months. 256 patients (25%) died 58±41 months after implant. The setting was secondary prevention in 498 patients (48%). No risk factors was present in 32% of patients, 1 in 27%, 2 in 20% and &gt;2 in 21%, respectively. There was a significant and comprehensible relation between risk score and mortality. Cumulative survival was 82% in patients with 0 risk factors, 63% in those with 1, 41% in those with 2 and 23% in those with &gt;2 risk factors (p &lt; 0.0001). ICD therapies were documented in 421 patients (41%) without correlation to risk factors.


CONCLUSIONS
In a mixed population of primary and secondary preventive ICD carriers, application of a simple risk score predicts long-term mortality but not appropriate use of the ICD.</dc:description>
  <dc:identifier>https://sonar.ch/global/documents/232224</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1136/heartjnl-2013-305002</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/24415667</dc:relation>
  <dc:source>Heart (British Cardiac Society). - 2014</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Implantable cardioverter defibrillator</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">sudden cardiac death</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">ventricular fibrillation</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">ventricular tachycardia</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Aged</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Death, Sudden, Cardiac</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Defibrillators, Implantable</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Female</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Follow-Up Studies</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Humans</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Kaplan-Meier Estimate</dc:subject>
  <dc:subject xmlns:ns12="xml" ns12:lang="en">Male</dc:subject>
  <dc:subject xmlns:ns13="xml" ns13:lang="en">Middle Aged</dc:subject>
  <dc:subject xmlns:ns14="xml" ns14:lang="en">Prognosis</dc:subject>
  <dc:subject xmlns:ns15="xml" ns15:lang="en">Retrospective Studies</dc:subject>
  <dc:subject xmlns:ns16="xml" ns16:lang="en">Risk Assessment</dc:subject>
  <dc:subject xmlns:ns17="xml" ns17:lang="en">Secondary Prevention</dc:subject>
  <dc:subject xmlns:ns18="xml" ns18:lang="en">Survival Rate</dc:subject>
  <dc:subject xmlns:ns19="xml" ns19:lang="en">Switzerland</dc:subject>
  <dc:subject xmlns:ns20="xml" ns20:lang="en">Tachycardia, Ventricular</dc:subject>
  <dc:title xmlns:ns21="xml" ns21:lang="en">Application of a mortality risk score in a general population of patients with an implantable cardioverter defibrillator (ICD).</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
